Biocon Biologics secures multiple market access agreements in US for Yesintek Ruchika Sharma5 May 2025 12:50 PM ISTYESINTEK is a monoclonal antibody that disrupts IL-12 and IL-23 mediated signaling associated immune mediated diseases.
Early Crohn's disease detection with capsule endoscopy improve long-term prognosis, finds study Jacinthlyn Sylvia20 April 2025 8:45 PM ISTA recent study by Yuya Ogino and colleagues created a scoring model for early Crohn's disease (CD) diagnosis based on results from small bowel capsule...
USFDA nod to JnJ Tremfya for Crohn's disease Ruchika Sharma21 March 2025 10:30 AM ISTHorsham: Johnson & Johnson has announced that the Company ahs received approval from the U.S. Food and Drug Administration (FDA) for TREMFYA...
Inflammatory Bowel Disease Linked to Increased Stroke Risk, claims study Dr Riya Dave28 Feb 2025 7:45 AM ISTA new study published in BMC Gastroenterology identified that patients with inflammatory bowel disease (IBD), such as Crohn's disease (CD) and...
Biocon Biologics unveils Yesintek biosimilar to Stelara in US Ruchika Sharma25 Feb 2025 12:31 PM ISTYESINTEK will be available in all the same formulations currently provided by Stelara.
Biocon Biologics Yesintek gets European Commission approval for plaque psoriasis, psoriatic arthritis Ruchika Sharma18 Feb 2025 3:42 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the European...
Inflammation may explain stomach problems in psoriasis sufferers, reveals research Dr. Kamal Kant Kohli20 Jan 2025 8:30 PM ISTPeople with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for 'leaky gut',...
Wearable devices can detect and predict inflammatory bowel disease flare-ups, Mount Sinai study finds Dr. Kamal Kant Kohli17 Jan 2025 9:45 PM ISTWearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease...
USFDA approves Eli Lilly Omvoh for Crohn's disease Ruchika Sharma16 Jan 2025 11:30 AM ISTIndianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Omvoh (mirikizumab-mrkz) for...
Approval of Biocon Biologics Yesintek recommended by EMA Committee Ruchika Sharma16 Dec 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the European...
ELi Lilly Omvoh recommended by CHMP for approval in EU for adults with moderately to severely active Crohn's disease Ruchika Sharma14 Dec 2024 10:30 AM ISTIndianapolis: Eli Lilly and Company has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for...
AGA Issues Key Guidance on Diet and Nutrition in IBD Management: Focus on Malnutrition and Tailored Therapies Medha Baranwal10 Dec 2024 8:30 AM ISTUSA: The American Gastroenterological Association (AGA) has released a new Clinical Practice Update (CPU) focusing on the role of diet and nutritional...
